Melissa A. Yeager, J.D.
SVP Regulatory Affairs and Quality
Jaguar Health
|
Melissa A. Yeager, J.D.
|
||
Melissa joins Jaguar Health with 20 years of experience developing biopharmaceuticals. Companies she has lead regulatory affairs are: Alder Pharmaceuticals, Breath Therapeutics, Gilead, and Corus.
Melissa brings strategic thinking, team building and a track record of product approvals to the Jaguar Health portfolio.
Welcome to The Jaguar Health team, Melissa!
|
 |
|
Jaguar Health, Inc. (NASDAQ: JAGX) is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Their wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Their Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Learn more at www.jaguar.health
|
